Executive Director, Global Medical Affairs, Hematology

BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.

The Global Executive Medical Science Director (ex-China) for Hematology GMA will report directly to the Vice President, Hematology Lead for GMA. Under the direction of the VP, She/he will be responsible for developing and implementing all aspects of the global medical strategy for BeOne Hematology assets. The primary focus will be to lead and ensure execution of all programs and functions associated with BeOne Medicine’s Hematology programs in Chronic Lymphocytic Leukemia (CLL), mantle cell and marginal zone Lymphomas (MCL, MZL) and Waldenstrom Macroglobulinemia (WM). In addition to leading the strategy and executional elements of phase IV (post-marketing) and investigator initiated studies program, the role includes broad collaboration with colleagues from clinical development and commercial, in particular for launch preparation and execution and to overall ensure that cross functional plans and activities across benefit from the insight of an experienced clinician.

The incumbent will bring an innovative mentality and fresh perspective to the generation of evidence and use of data to inform and accelerate business decisions for our hematology products as well as support healthcare decisions by patients, physicians, and payers. She will need excellent strategic, execution, collaboration and communication skills, as well as an entrepreneurial approach, to work with and through others.

Key Responsibilities

Overall Global Medical Strategy & execution

• Under supervision and direction of the VP Hematology for GMA, contributes and/or co-leads the cross-functional Global Medical Team for Hematology, develops and updates as need be the overall Global Medical Plan for one or more late stage hematology molecules and any other relevant hematology asset, including
• medical launch strategic and tactical plans.
• integrated evidence generation plans, incl. but not limited to medical affairs clinical studies, Investigator Initiated Studies (IIS) and RWD.
• Advisory board plans.
• External engagement plans.
• Scientific communication: publication plans, congress presentations, MSL materials.
• Medical Education plans.
• Represents the GMA function on the Global Product Team(s).
• Contributes to the identification of potential medical interests for line extensions according to scientific rationale and good understanding of the actual and anticipated future directions of medical practice.
• Assesses the needs and coordinates compassionate use together with heads of regions for the assigned product(s).
• Drives the execution of medical tactics and deliverables, in collaboration with other medical and non-medical functions as needed and appropriate.
• Reviews and assesses all IIS proposals as per BeOne IIS review process and ensures it is consistent with the asset strategy and identified data gaps.
• Prepares and leads or co-leads with the VP Hematology for GMA, the scientific advisory board meetings for the assigned product(s).

External Collaborations

• Under supervision and direction of the VP Hematology lead GMA, develops and maintains interactions and collaborations with therapeutic experts and scientific entities, incl. those aimed to set up and conduct evidence generation activities for MCL, WM, MZL and CLL specifically.
• In close collaboration with the GMA Patient engagement & Professional Societies Lead and the Corporate patient advocacy group, actively supports BeOne engagement of patients and patient groups and incorporates insights from these stakeholders into all relevant plans and tactics.
• Represents BeOne Medicines in peer-to-peer interactions with external collaboration partners, including in patient-company interactions.

Collaboration with regional and country medical teams

• Ensures the cascading and understanding of the global medical plans by medical teams in all regions and countries and drives alignment of local/regional medical plans to the approved global strategy.
• Where exceptions are needed, supports minimization of local deviations and documentation of the cross functional reviews & approvals of said deviation by the global team.
• Regularly liaises with regional/local leads for hematology to gather and incorporate feedback and insights from the markets into the global strategy and plans.
• As appropriate, supports local/regional external engagement projects by attending meetings, presenting data